Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rowfarma is a Mexican pharmaceutical company dedicated to the development, manufacturing, and commercialization of high-quality branded generic medications. The company maintains a significant presence in the Mexican healthcare market, focusing on therapeutic areas such as the central nervous system, pain management, cardiology, and gastroenterology. Rowfarma operates GMP-certified manufacturing facilities to ensure that its products meet rigorous safety and efficacy standards. Its portfolio includes widely recognized brands like Gabax and Rowfast, which provide affordable treatment options for conditions such as neuropathic pain and hypertension. By leveraging a robust distribution network, Rowfarma ensures its medications are accessible to patients across both the private and public sectors in Mexico.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rowfarma.